"S" SARS-CoV-2 Spike Glycoprotein mRNA (10 µg, Transfection-ready)
Catalogue Number: CVD19-430A-1-SBI
| Manufacturer: | System Biosciences |
| Type: | mRNA |
| Shipping Condition: | Dry Ice |
| Unit(s): | 10 ug |
Description
Description: With transfection-ready “S” SARS-CoV-2 Spike Glycoprotein mRNA, you can easily study infectivity and other interactions of the native SARS-CoV-2 spike glycoprotein from the original Wuhan-1 strain. The “S” SARS-CoV-2 Spike Glycoprotein mRNA delivers robust transient expression to support a range of spike glycoprotein studies.Speed your studies with ready-to-transfect mRNATransiently express the native (not codon optimized) SARS-CoV-2 spike glycoproteinStable SARS-CoV-2 spike glycoprotein expression is also available as pre-packaged transduction-ready lentivirus, ready-to-package lentivector, and as a human codon-optimized constructSupporting Data“S” SARS-CoV-2 Spike Glycoprotein mRNA is of high-qualityThe high quality of the “S” SARS-CoV-2 Spike Glycoprotein mRNA can be seen in Figure 1, which shows that the majority of the in vitro transcribed mRNA migrates as a single species on a 1.5% denaturing agarose gel. A small proportion of the transcript is truncated (indicated by the *) due to an internal sequence in the Spike mRNA that causes T7 polymerase to pause. Figure 1. The “S” SARS-CoV-2 mRNA is a high-quality mRNA construct that migrates primarily as a single species.
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations